Memorial Sloan Kettering Cancer Center at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Memorial Sloan Kettering Cancer Center brings 9 presentations to AMP 2026 in Seattle. Its program centres on circulating tumour DNA for residual disease, variant interpretation in cancer, and molecular profiling of tumours in younger patients. Its informatics work draws on data from 100,000 patients with cancer and applies AlphaMissense to missense mutations in DNA damage repair genes.

OrganizationAMP 2026 Attendance
mskcc.org
Med centres
Cancer hospital and research institute in New York with a large clinical tumour sequencing and molecular diagnostics programme.
Session
Thu, Nov 12
1:15pm–2:15pm
Talk
Thu, Nov 12
2:30pm–3:00pm
Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting
AMP Clinical Validation of cfDNA and ctDNA Assays Working Group
Setting validation standards for liquid biopsy assays in oncology, with attendee input shaping the guideline under development.
Ballroom E, Level 6, Arch at 705 Pike
Talk
Thu, Nov 12
3:00pm–3:30pm
Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting
AMP Copy Number Alterations Working Group
Copy number alterations called from sequencing: how those assays are validated, reported and read next to FISH, cytogenetics and microarray.
Ballroom E, Level 6, Arch at 705 Pike
Workshop
Thu, Nov 12
4:25pm–4:55pm
Want to get involved with AMP?
Volunteering pathways in the professional society, from short time-limited tasks through committee membership and leadership roles.
Innovation Spotlight Stage #3
Session
Fri, Nov 13
10:15am–11:45am
Talk
Fri, Nov 13
11:15am–11:45am
Part of Resolving the Unknown: Functional and Computational Approaches to Determine Pathogenicity of Genetic Variants
AlphaMissense for Identifying Pathogenic Missense Mutations in DNA Damage Repair Genes in Cancer
Using AlphaMissense and related AI tools to flag pathogenic missense variants in DNA damage repair genes in cancer.
611-614, Level 6, Arch at 705 Pike
Genetics
Talk
Fri, Nov 13
1:15pm–2:45pm
Part of Optimizing Computational Infrastructure for High-throughput Clinical Data
Data Analysis, Interpretation, and Discovery in 100,000 Patients With Cancer
Combining somatic, germline and clinical data from over 100,000 cancer patients to support variant interpretation, trials and discovery.
611-614, Level 6, Arch at 705 Pike
Informatics
Session
Sat, Nov 14
10:15am–11:45am
Update on the Role of CtDNA-Based Detection of MRD in Clinical Trials and Beyond for Solid Tumors
Ballroom E, Level 6, Arch at 705 Pike
Solid Tumors
  1. 10:15am–11:00amMinimal Residual Disease in Colorectal Cancer: Opportunities for therapeutic developmentThe University of Texas MD Anderson Cancer Center, Houston, TX
  2. 11:00am–11:45amLiquid Biopsy Biomarkers for Early Detection of Treatment Response and Disease MonitoringMCGill University, Research Institute of the McGill University Health Centre
Session
Sat, Nov 14
1:15pm–2:15pm
Platform Presentations of Selected Solid Tumor Abstracts II
611-614, Level 6, Arch at 705 Pike
  1. 1:15pm–1:30pmST026 Comparative Analysis of Copy Number Variant Detection from DNA Methylation Arrays Against Targeted Next-Generation Sequencing in a Pan-Cancer CohortNYU Langone Health
  2. 1:30pm–1:45pmST074 Integration of Longitudinal ctDNA Sequencing and Quantitative ESR1 Mutation Analysis to Inform Molecular Monitoring Strategies in Metastatic Breast CancerEarle A Chiles Research Institute, Providence Health
  3. 1:45pm–2:00pmST015 Clinical Evaluation of Whole Genome Enzymatic Methylation Sequencing for Integrated Classification and Copy Number Profiling of Pediatric Central Nervous System TumorsChildren's Hospital Los Angeles, University of Southern California
  4. 2:00pm–2:15pmST093 Tumor Cellularity Limits Next-Generation Sequencing Sensitivity for MTAP Loss: Post-Validation Next-Generation Sequencing-Immunohistochemistry Concordance in a Large Single-Institution CohortM.D. Anderson Cancer Center

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Memorial Sloan Kettering Cancer Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction